Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
2,603,370
-
Shares change
-
-9,726
-
Total reported value, excl. options
-
$260,419,500
-
Value change
-
-$912,880
-
Number of buys
-
30
-
Number of sells
-
-34
-
Price
-
$100
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2021
81 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q4 2021.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,603,370 shares
of 3,203,885 outstanding shares and own 81.26% of the company stock.
Largest 10 shareholders include FMR LLC (467,723 shares), PRICE T ROWE ASSOCIATES INC /MD/ (342,675 shares), RENAISSANCE TECHNOLOGIES LLC (222,914 shares), BlackRock Inc. (217,007 shares), VANGUARD GROUP INC (189,573 shares), DIMENSIONAL FUND ADVISORS LP (150,101 shares), RICE HALL JAMES & ASSOCIATES, LLC (113,833 shares), JPMORGAN CHASE & CO (87,069 shares), Russell Investments Group, Ltd. (78,498 shares), and STATE STREET CORP (68,934 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.